Physician

Jhansi Lakshmi Ganji, MD

According to 2025 Medicare claims, Jhansi Ganji, MD (NPI: 1477994432) practices endocrinology in the Gettysburg, PA market, with the plurality of this provider's patient population coming from Adams, PA. This provider's primary affiliated billing organization is WELLSPAN MEDICAL GROUP (NPI: 1578623781; TIN: 23-2730785) and primary practice location at 17325-7878. Ganji is affiliated with the WellSpan Population Health Services (ACO ID: A2500), participating under the MSSP model.

Ganji's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 595 traditional Medicare patients, billed 7,101 HCPCS/CPT codes, and received $200,258 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 9,682 prescription claims across 810 beneficiaries totaling $4,220,351 in drug costs, led by Ozempic (Semaglutide). DME data shows 1,041 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $14,906 to $200,258. Similarly, Part D prescription costs have moved sharply higher in recent years, from $1,466 to $4,220,351. For DME billing, reported payments moved sharply higher in recent years, from $1,020 to $355,225.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	104	180	$14,906
2019	272	701	$52,184
2020	308	981	$60,904
2021	479	1,991	$112,734
2022	514	3,034	$125,551
2023	592	7,408	$178,711
2024	595	7,101	$200,258

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	13	$1,466
2016	45	135	$26,016
2017	97	1,075	$239,307
2018	137	1,054	$233,083
2019	251	1,649	$666,059
2020	291	3,110	$1,535,601
2021	489	4,488	$2,253,812
2022	579	6,192	$3,405,210
2023	704	7,494	$4,038,769
2024	810	9,682	$4,220,351

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	32	98	$1,007
2018	20	91	$775
2019	42	155	$18,636
2020	117	577	$74,755
2021	218	1,050	$150,071
2022	256	1,424	$240,022
2023	296	1,586	$285,131
2024	287	1,041	$364,418

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	144	181	$124
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	490	831	$84
95251	Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report	174	377	$25
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	298	404	$12
82962	Blood glucose (sugar) test performed by hand-held instrument	82	108	$3

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ozempic	Semaglutide	795	34,282	$1,019,695
Jardiance	Empagliflozin	713	38,171	$706,529
Trulicity	Dulaglutide	479	17,078	$555,211
Mounjaro	Tirzepatide	331	11,066	$392,423
Tresiba Flextouch U-200	Insulin Degludec	182	8,997	$174,658

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	166	686	$317,729
J1817	Insulin for administration through dme (i.e., insulin pump) per 50 units	N	N/R	57	$14,444
A4224	Supplies for maintenance of insulin infusion catheter, per week	N	13	43	$10,738
E0784	External ambulatory infusion pump, insulin	Y	N/R	34	$10,214
E2103	Non-adjunctive, non-implanted continuous glucose monitor or receiver	N	25	25	$4,975

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Jhansi Lakshmi Ganji, MD?

Tedicare shows public-source Medicare data for Jhansi Lakshmi Ganji, MD (NPI 1477994432), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jhansi Lakshmi Ganji, MD have ACO affiliation data?

Jhansi Lakshmi Ganji, MD is shown with ACO affiliation data for WellSpan Population Health Services (MSSP, ACO ID A2500).

What billing organization is linked to Jhansi Lakshmi Ganji, MD?

Jhansi Lakshmi Ganji, MD is linked to WELLSPAN MEDICAL GROUP (billing NPI 1578623781) in the available physician profile data.

Does Jhansi Lakshmi Ganji, MD have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.